Clinical Trial Update: AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight [Phase 3]

View source ↗

Summary

This update reports an ongoing Phase 3 clinical trial (AMAZE 1) evaluating the weight-loss medicine NNC0487-0111 in adults with obesity, with participant recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: RECRUITING